Patents Assigned to Priothera Limited
  • Treatment of graft versus host disease in transplant patients
    Patent number: 11224604
    Abstract: The present invention relates to a method of treating patients who undergo hematopoietic stem cell transplantation (HSCT) with peripheral blood mobilized stem cells for hematological malignancies and for whom the risk for severe acute graft versus host disease (GVHD) is considerable.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: January 18, 2022
    Assignee: PRIOTHERA LIMITED
    Inventors: Peter Gergely, Kazuhiko Kuriyama
  • TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
    Publication number: 20210346317
    Abstract: The present invention relates to a method of accelerating stem cell engraftment in a patient in need of hematopoietic stem cell transplantation.
    Type: Application
    Filed: May 25, 2021
    Publication date: November 11, 2021
    Applicant: PRIOTHERA LIMITED
    Inventors: Christoph BUCHER, Peter GERGELY, Andreas KATOPODIS, Philip SMITH
  • AGENT FOR INHIBITING RECURRENCE OF HEMATOLOGICAL MALIGNANCY IN PATIENTS WHO HAVE UNDERGONE HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Publication number: 20210283073
    Abstract: A pharmaceutical preparation that inhibits recurrence of hematological malignancies and/or improves survival rates, in patients who have undergone hematopoietic stem cell transplantation for the treatment of hematological malignancies, which contains 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl] ethyl-propane-1,3-diol or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: July 26, 2019
    Publication date: September 16, 2021
    Applicant: Priothera Limited
    Inventors: Claudia CORRADO, Christoph BUCHER, Julie JONES, Peter GERGELY